or
forgot password
  • cancer clinical trials in durham, NC

  • Trastuzumab in Treating Older Women With Early-Stage Breast Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Breast Cancer
    Study of Sorafenib/Cetuximab in Head and Neck Cancer
    Duke University Health System
    Durham, North Carolina 27705
    Squamous Cell Cancer
    GDC-0449 in Treating Young Patients With Medulloblastoma That is Recurrent or Did Not Respond to Previous Treatment
    Duke University Medical Center
    Durham, North Carolina 27710
    Recurrent Childhood Medulloblastoma
    Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Renal Cell Carcinoma, Renal Cancer
    Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes
    Duke University Medical Center
    Durham, North Carolina 27710
    Myelodysplastic Syndromes
    Skin Cancer Prevention
    VA Medical Center, Durham
    Durham, North Carolina 27705
    Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Skin Neoplasms, Skin Diseases, Neoplasms, Basal Cell, Neoplasms, Squamous Cell, Carcinoma
    Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
    Duke University Medical Center
    Durham, North Carolina 27710
    Ovarian Cancer
    Monthly SOM230C for Recurrent or Progressive Meningioma
    Duke University Medical Center, Preston Robert Tisch Brain Tumor Center
    Durham, North Carolina 27710
    Meningioma
    Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Lung Cancer
    Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Peripheral T-cell Lymphoma
    Strategic Timing of Antiretroviral Treatment
    Duke University
    Durham, North Carolina 27710
    HIV Infection
    Five Year Adjuvant Imatinib Mesylate (GleevecĀ®) in Gastrointestinal Stromal Tumor (GIST)
    Duke University Medical Center Duke University
    Durham, North Carolina 27710
    Gastrointestinal Stromal Tumor (GIST)
    Erectile Dysfunction Study
    Duke University Medical Center
    Durham, North Carolina 27710
    Erectile Dysfunction
    A Study Evaluating Ultratrace Iobenguane I 131(MIBG)in Patients With Malignant Pheochromocytoma/Paraganglioma
    Duke University Medical Center
    Durham, North Carolina 27710
    Pheochromocytoma, Paraganglioma
    A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
    Duke University School of Medicine
    Durham, North Carolina 27710
    Venous Thromboembolism, Pulmonary Embolism
    Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors
    Duke University Medical Center
    Durham, North Carolina 27710
    Solid Tumors
    Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Duke Comprehensive Cancer Center
    Durham, North Carolina 27710
    Endometrial Cancer
    Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme
    Duke University Medical Center
    Durham, North Carolina 27710
    Recurrent Central Nervous System Neoplasm
    Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
    Duke Cancer Institute
    Durham, North Carolina 27710
    Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
    Study of Kidney Tumors in Young Patients
    Duke Cancer Institute
    Durham, North Carolina 27710
    Kidney Cancer, Nonneoplastic Condition
    Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
    Duke Cancer Institute
    Durham, North Carolina 27710
    Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
    Duke Cancer Institute
    Durham, North Carolina 27710
    Sarcoma
    Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
    Duke Cancer Institute
    Durham, North Carolina 27710
    Sarcoma
    Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
    Duke Cancer Institute
    Durham, North Carolina 27710
    Lymphoma
    Cervical Cancer Detection Using Optical Spectroscopy
    Duke University Medical Center
    Durham, North Carolina 27710
    Cervical Cancer
    Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant
    Duke University Medical Center
    Durham, North Carolina 27710
    Multiple Myeloma, Non-Hodgkins Lymphoma, Hodgkins Disease
    Open Label Study of Sipuleucel-T
    GU Oncology Research Program
    Durham, North Carolina 27710
    Prostate Cancer
    Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Oral Mucositis
    Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing
    Duke University Medical Center
    Durham, North Carolina 27710
    Advanced Cancers, Hematologic Diseases, Solid Tumors
    Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Head and Neck Squamous Cell Carcinoma
    Statins and Breast Cancer Biomarkers
    Duke University
    Durham, North Carolina 27710
    Breast Cancer
    Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Prostate Cancer
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    Duke University Medical Center
    Durham, North Carolina 27710
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib
    Duke Univeristy Medical Center
    Durham, North Carolina 27710
    Solid Tumor, Metastatic Colorectal Cancer
    Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies
    Duke University Medical Center
    Durham, North Carolina 27710
    Non Small Cell Lung Cancer, Small Cell Lung Cancer, Thymoma, Thymus Neoplasms
    Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Breast Cancer
    Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
    Duke Cancer Institute
    Durham, North Carolina 27710
    Prostate Cancer, Sexual Dysfunction
    Atkins Diet and Prostate Cancer Clinical Trial
    Duke University Medical Center
    Durham, North Carolina 27710
    Prostate Cancer
    Enhanced Self-Efficacy Training
    Duke University Medical Center
    Durham, North Carolina 27710
    Neoplasms
    Uncertainty Management Intervention
    Duke University
    Durham, North Carolina 27710
    Liver Diseases
    Outlook: An Intervention to Improve Quality of Life in Serious Illness
    Duke University Medical Center
    Durham, North Carolina 27710
    Neoplasms, Pulmonary Disease, Chronic Obstructive, Heart Failure, Renal Disease
    Study of Cabozantinib (XL184) in Adults With Advanced Malignancies
    Duke University Medical Center
    Durham, North Carolina 27710
    Solid Tumors, Cancer
    Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer
    Duke University
    Durham, North Carolina 27710
    Breast Cancer
    Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Prostate Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Cancer
    Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
    Duke University Medical Center
    Durham, North Carolina 27710
    Diffuse Hyperplastic Perilobar Nephroblastomatosis, Rhabdoid Tumor of the Kidney, Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor, Stage IV Wilms Tumor, Stage V Wilms Tumor
    Stem Cell Related Donor Safety Study
    Duke University Medical Center
    Durham, North Carolina 27710
    Related Hematopoietic Stem Cell Donors
    Study of Patients With Advanced Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Durham, North Carolina
    Advanced Non-Small Cell Lung Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Duke University Medical Center
    Durham, North Carolina 27710
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Treatment of Blood Clots in Children With Cancer
    Duke Children's Hospital
    Durham, North Carolina 27710
    Venous Thromboembolism
    Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG)
    Duke University Health System
    Durham, North Carolina 27705
    Malignant Glioma
    Study of Blood Samples From Newborns With Down Syndrome
    Duke Cancer Institute
    Durham, North Carolina 27710
    Leukemia
    Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
    Duke University Medical Center; The Preston Robert Tisch Brain Tumor Center
    Durham, North Carolina 27710
    Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma
    Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease
    Division of Medical Genetics, Duke University Medical Center
    Durham, North Carolina 27710
    Gaucher Disease
    GE Healthcare VolumeRAD Lung Nodule Detection Study
    Duke University Medical Center
    Durham, North Carolina 27710
    Pulmonary Nodule, Solitary, Multiple Pulmonary Nodules
    A Phase 1/2 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia
    Duke University Medical Center
    Durham, North Carolina 27710
    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Blastic Phase Chronic Myelogenous Leukemia, CML
    PRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate Biopsy
    Duke University Medical Center

    Trial Locations
    Duke University Medical Center
    Durham VA Medical Center
    Prostate Cancer